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Summary
  Crusted scabies is a highly infectious, debilitating and 
disfi guring disease, and remote Aboriginal communities 
of northern Australia have the highest reported rates of 
the condition in the world.
  We draw on monitoring data of the East Arnhem 
Scabies Control Program to discuss outcomes and 
lessons learnt through managing the condition in 
remote communities.
  Using active case fi nding, we identifi ed seven patients 
with crusted scabies in three communities and found 
most had not presented to health services despite 
active disease. We compared presentations and 
hospitalisations for a cumulative total of 99 months 
during a novel preventive program with 99 months 
immediately before the program for the seven cases and 
seven sentinel household contacts.
  Our preventive long-term case management approach 
was associated with a signifi cant 44% reduction in 
episodes of recurrent crusted scabies (from 36 to 20; 
P = 0.025) in the seven cases, and a non-signifi cant 
80% reduction in days spent in hospital (from 173 to 35; 
P = 0.09). It was also associated with a signifi cant 75% 
reduction in scabies-related presentations (from 28 to 7; 
P = 0.017) for the seven sentinel household contacts.
  We recommend active surveillance and wider adoption 
of this preventive case management approach, with 
ongoing evaluation to refi ne protocols and improve 
effi  ciency.
  Contacts of children presenting with recurrent scabies 
should be examined to exclude crusted scabies. 
In households where crusted scabies is present, a 
diagnosis of parental neglect due to recurrent scabies 
and weight loss in children should be made with 
extreme caution.
  Improved coordination of care by health services, and 
research and development of new therapies including 
immunotherapies for crusted scabies, must be a priority.
Crusted scabies in remote Australia, a new 
way forward: lessons and outcomes from 
the East Arnhem Scabies Control Program
 Crusted scabies is a highly infectious, debilitating and disfi guring condition (Box 1) that develops when scabies mite proliferation is not controlled by the 
host immune system. It is characterised by hyperkera-
totic skin crusts and mite loads of a million or more on 
affected individuals (up to 4700 mites per gram of skin), 
compared with a total of 10–15 mites in simple scabies.2 
Crusted scabies is generally seen in immunocompromised 
patients3 and historically had a 5-year mortality rate of up 
to 50%.4 However, a multidose regimen of ivermectin, ben-
zyl benzoate and keratolytic agents introduced in 1996 at 
the Northern Territory’s Royal Darwin Hospital has led to 
a signifi cant decrease in the annual mortality rate, to 1.6%.4 
Unmanaged crusted scabies is known to cause outbreaks of 
simple scabies and contributes to the hyperendemic rates 
seen in many remote communities.4,5
 While rare in urban settings, rates of crusted scabies 
reported in remote Aboriginal communities of northern 
Australia are the highest in the world.4,6 A review of 78 
patients admitted to hospital for crusted scabies in north-
ern Australia over 10 years found nearly all (97%) were 
Aboriginal people from remote communities, and in nearly 
half of these patients no underlying immune defect was 
found.4 From its inception in early 2011 to April 2014, active 
case fi nding by the East Arnhem Scabies Control Program 
(EASCP) across 11 remote communities of northern 
Australia and their homelands had confi rmed 20 cases (1.8 
cases per 1000 population).
There is currently no register or follow-up of people liv-
ing in scabies-endemic areas who are at risk of developing 
recurrent crusted scabies. Recurrences are only detected if 
patients self-present to health services and are seen by a cli-
nician familiar with the condition. Current protocols treat 
the condition acutely. The EASCP postulated that the lack 
of follow-up surveillance and chemoprophylaxis was inad-
equate for patients returning to endemic areas.
Here, we present results of routine monitoring and evalu-
ation of the EASCP between August 2011 and June 2013, 
from the three remote East Arnhem communities in the 
NT where we had data sharing agreements to access clini-
cal records and the operational capacity to deploy a preven-
tive program. Individual consent was obtained to publish 
case history details. Publication of EASCP monitoring data 
Case record
An 8-year-old girl had received treatment for scabies at a health 
centre in a remote Northern Territory Arnhem Land community on 
32 occasions since her birth. Seventeen of these occasions required 
treatment with parenteral antibiotics for secondary infection. 
Many episodes were noted to involve the “whole body” and on two 
occasions she had required hospitalisation. During this time, she was 
also found to have a low body mass index and failure to thrive.
The girl was often found crying from pain and itch and had been 
excluded from school for extended periods because of her infectivity. 
Her family reported that she was bullied by her peers because of the 
disfi gurement of her skin. Her frequent bouts of disfi guring scabies, 
skin sores and weight loss had led to referrals to child and family 
services over concerns of parental neglect.
The girl was brought to the attention of East Arnhem Scabies 
Control Program staff  in 2011. Contact tracing was initiated, and a 
senior member of the family, with whom the girl shared a room, was 
found to have Grade 2 (moderate) crusted scabies. Clinical audits 
showed that the senior family member had repeatedly presented 
with crusted scabies since 1996. After a hospital admission in 2006, 
she had avoided contact with health services, even though her 
skin condition deteriorated, reportedly due to fear of the treatment 
regimen involving extended isolation in hospital and the use of 
creams that caused a burning skin sensation.
The senior family member was subsequently treated for crusted 
scabies and the girl and other household members were treated for 
simple scabies. The woman was then enrolled in a pilot program to 
prevent recurrent disease. During 19 months of follow-up with the 
preventive regimen in place for the woman, the girl’s skin condition 
improved and required no further specifi c management other than 
treatment for scabies on one occasion.
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was approved by the board of Miwatj Health Aboriginal 
Corporation and the Human Research Ethics Committee 
of the NT Department of Health and Menzies School of 
Health Research (approval number 2013-2055).
The East Arnhem Scabies Control Program
The EASCP was established in early 2011 and is a joint initi-
ative of One Disease, Miwatj Health Aboriginal Corporation 
and the NT Government Department of Health. The con-
sultancy EveryVoiceCounts was contracted to design the 
program and guide implementation. More information on 
the EveryVoiceCounts learning partnership model used to 
design the program is available at http://www.everyvoice 
counts.org/scabies-partnership. For more on the EASCP, 
see https://1disease.org.
 The EASCP was developed to enhance regional efforts 
to reduce the impact of scabies as a public health problem 
in remote communities of Arnhem Land and is a service 
delivery program integrated into existing health services. 
The program’s fi rst goal was to reduce the burden of crusted 
scabies on affected individuals and households in par-
ticipating East Arnhem communities. This goal was the 
result of consultations and baseline clinical audits that 
indicated a signifi cant burden of illness and ongoing dis-
ruption to quality of life arising from unmanaged crusted 
scabies. Patients we encountered in remote communities 
in 2011 suffered similar stigma and disfi gurement to those 
described in a case report of crusted scabies published more 
than 60 years earlier (Box 1).1 The EASCP also recognised 
that better management of these “core transmitters” was 
a founda tion of broader scabies control efforts.
In late 2011, the EASCP convened a medical working 
group to update the scabies and crusted scabies guidelines 
in the Central Australian Rural Practitioners Association 
(CARPA) Standard treatment manual. Drawing on expe-
rience with a patient who had successfully used short-
term treatment creams in a preventive fashion, as well as 
a preventive model proposed in 2004,7 the working group 
approved a provisional protocol to prevent recurrences of 
crusted scabies, which the EASCP then trialled.
EASCP crusted scabies case management protocol
The EASCP used active case fi nding to identify people 
with crusted scabies. When cases were confi rmed in one 
of the three communities where EASCP had operations, 
the patients were fi rst treated (in hospital or, when this was 
declined, in the community) using a protocol developed by 
the Royal Darwin Hospital.8,9 Patients were then enrolled 
in the new preventive care regimen, which involved:
• regular (every 1–4 weeks) skin checks looking for signs 
of recurrent crusted scabies;
• frequent use of a keratolytic cream (to limit the build-up 
of keratin crusts, where mites live and multiply in crusted 
scabies) combined with a moisturiser; and
• regular (every 2–4 weeks) use of a scabies (acaricide) 
cream. The frequency depended on the likely level of 
recurrent exposure to mites (eg, in a household with 
many young children, fortnightly applications were 
used). Benzyl benzoate was selected because of the lim-
ited risk of resistance developing with this agent. An 
initial test application of benzyl benzoate ruled out the 
side effect of transient burning sensation on the skin.
This clinical protocol was implemented by the EASCP 
through a long-term household case management approach, 
focused on developing therapeutic rapport with patients and 
senior members of households. The EASCP’s early consul-
tations with care providers and patients highlighted sign-
ifi cant fear and stigma associated with the disease and a 
reluctance to engage with health services. Given the chron-
icity of the disease, the long-term goal was adherence to 
the treatment regimen and ultimately self-management 
of the condition. We aimed to achieve this through con-
sistency of staff, regular supply of the preventive creams 
needed for self-management, and reinforcing the house-
hold costs of disease recurrence.
Active case fi nding and EASCP inclusion criteria
Cases
From August 2011, the EASCP investigated patients identi-
fi ed by health centres as having recurrent scabies or crusted 
scabies. The EASCP also examined the NT hospital data-
base and related discharge summaries to fi nd patients from 
participating communities who had been treated for crusted 
scabies. An experienced EASCP clinician then examined 
the patient and confi rmed or excluded the diagnosis of 
crusted scabies, and this was verifi ed by visiting derma-
tologists and infectious disease specialists.
1  The disfi guring plaques of crusted scabies
A: Photograph of crusted scabies reproduced from a 1948 case report.1 B: Crusted scabies of the elbow. C: Crusted scabies of the foot (partially treated).  
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Sentinel contacts
EASCP monitoring paired each confi rmed case with a 
household child contact. The contacts served as sentinels 
of recurrent disease in the cases and to track their infec-
tivity, as our baseline data showed that most patients with 
active disease did not present to health services. Contacts 
were confi rmed to have the same primary residence as the 
cases with whom they were paired. Crusted scabies was 
excluded in the contacts. Sentinel contacts often had a his-
tory of recurrent simple scabies and had been referred to 
the EASCP for management. Due to capacity constraints, 
where multiple contacts were known to the EASCP, the 
contact with the most extensive history of presentation for 
scabies was selected as the sentinel.
Evaluation of EASCP case management 
protocol
Between August 2011 and June 2013, seven patients in 
the three communities under evaluation were confi rmed 
as having crusted scabies and were enrolled in preventive 
case management. These seven patients and their seven 
sentinel contacts are included in this review.
EASCP monitoring data consisted of EASCP, health 
centre and hospital clinical records before and after the 
preventive care protocol was introduced. The outcome 
measures examined were the number of presentations 
involving recurrences of crusted scabies in cases and recur-
rent simple scabies in contacts. To avoid double count-
ing, each new presentation was recorded as one episode 
(follow-up visits for multidose treatments were counted 
only once), and only one episode was recorded if presen-
tations led to referrals to hospital or the health centre for 
management. Search parameters for the outcome meas-
ures were consistent for the intervention (during preven-
tive case management) and control (before preventive case 
management) periods. However, screening of cases for 
recurrence was active (1–4-weekly skin checks) during the 
intervention period, but passive (self-presentation) during 
the control period. This is likely to signifi cantly bias results 
towards the null.
The duration of case management was from the time 
of case identifi cation and consent to June 2013. We exam-
ined the change in the number of outcome events during 
the intervention period compared with those during a pre-
intervention control period of the same duration for each 
case and contact. The Wilcoxon signed-rank test was used 
to determine statistical signifi cance, and P values < 0.05 
were considered signifi cant. Data were analysed using 
Stata version 11 (StataCorp).
Detailed baseline data and monitoring methods can be 
found in the Appendix (online at mja.com.au).
Baseline fi ndings
We audited a combined 57 years of clinical records for the 
seven cases (26 years) and seven contacts (31 years). Among 
cases, one patient was aged 20–39 years and six were aged 
40–59 years. Among contacts, three were aged 0–4 years, 
three were aged 5–9 years and one was aged 10–14 years.
No immune defect was recorded in the seven cases, apart 
from one patient who had crusting in a neuropathic limb. 
Six of the seven patients had active crusting of moderate to 
severe grade (ie, high infectivity) at the time of fi rst review 
by the EASCP. Of these six, four had not presented to health 
services despite having recurrent disease and were only 
identifi ed through active surveillance. Most (4/6) declined 
hospitalisation.
Cases presented with recurrent disease a median of fi ve 
times per year (range, 1–9) during the 26 years of record 
review. Paired sentinel contacts presented with simple 
scabies (with or without skin sores) a median of fi ve times 
per year (range, 0.4–11) during 31 years of record review. 
Combined case–contact pairs presented a median of 12 
times per year (range, 4–16) with presentations related to 
simple or crusted scabies during the combined 57 years of 
audited records.
Child contacts had a median of 10 presentations (range, 
5–11) for simple scabies and sores in their fi rst year of 
life, and most contacts had multiple episodes of scabies 
described as “extensive/whole body”. Nearly all of the paired 
child contacts had suffered periods of recurrent scabies and 
sores associated with weight loss and failure to thrive. Five 
of these children had been referred to child and family ser-
vices over concerns of parental neglect, where recurrent 
scabies and sores featured in the referral.
EASCP case management fi ndings
From August 2011 to June 2013, a cumulative total of 99 
months of preventive case management was undertaken 
in the seven cases (mean duration of enrolment in care, 
14 months; range, 3–20 months). Clinical records from a 
matching 99-month control period immediately before pre-
ventive case management were also reviewed, making a 
cumulative total of 198 months before and during the inter-
vention. Clinical records for the corresponding 198 months 
were examined for paired contacts.
During the 99-month intervention period, cases were 
reviewed at 1–4-weekly intervals. For the seven cases, a 
total of 245 skin checks were performed in the commun-
ity (every 1.6 weeks on average). The EASCP recorded no 
reports of adverse effects from the preventive treatment 
regimen.
For the seven cases, we detected a signifi cant 44% reduc-
tion in clinically diagnosed episodes of recurrence of crust-
ing (from 36 to 20; P = 0.025) during the intervention period, 
compared with the control period (Box 2). We also detected 
a 56% reduction in episodes of hospitalisation (from 9 to 
4; P = 0.09) and an 80% reduction in days spent in hospital 
as a result of recurrence of crusted scabies (from 173 to 35; 
P = 0.09), compared with the control period. However, these 
changes were not signifi cant and are due to the number of 
cases that had not recorded a hospitalisation and, in light 
of our baseline data, are likely to indicate non-presenters.
 For the seven paired contacts, we detected a statistically 
signifi cant 75% decrease in the combined number of hos-
pital admissions and presentations to local health centres 
with scabies and skin sores (from 28 to 7; P = 0.017) during 
the intervention period, compared with the control period 
(Box 2). We also detected a signifi cant 58% reduction in 
paired case–contact presentations (from 64 to 27; P = 0.016).
Limitations of the evaluation
The nature of the analysis (involving audit of program 
monitoring records) and the small sample size limit the 
647MJA 200 (11)  ·  16 June 2014
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generalisability of our fi ndings. The routine nature of data 
collection means there is interoperator variability, and dia-
gnoses made on clinical grounds allow for false-positive 
results. For cases, this is likely to be low because recurrences 
were based on detection of characteristic skin lesions in 
patients who had a hospital- or specialist-confi rmed history 
of crusted scabies. Importantly, the criteria were consist-
ent during the intervention and control periods. We believe 
our method of analysis is conservative, with the dominant 
bias being towards the null, as surveillance for recurrences 
was active during the intervention period, compared with 
passive surveillance during the control period. The use of 
a primary contact to track disease transmission also limits 
generalisability of the study. However, the contacts act as 
useful sentinels of recurrent disease and infectivity of cases. 
EASCP monitoring is ongoing, and subsequent analyses 
will improve the generalisability of fi ndings as the dura-
tion of follow-up and number of managed cases increases.
Lessons
EASCP’s program monitoring and evaluation fi ndings offer 
important lessons for the control of crusted and simple 
scabies in Australia.
Lesson 1: Current passive surveillance for recurrences leads to 
likely underdetection of crusted scabies in scabies-endemic areas.
Lesson 2: Combined presentations of cases and sentinel contacts 
suggest signifi cant scabies transmission from cases to house-
hold contacts, increasing the risk of complications from chronic 
renal and rheumatic heart disease. Repeated episodes of sca-
bies and skin sores are likely to signifi cantly impair house-
hold quality of life,10 and to increase the risk of repeated 
exposure to group A streptococcus isolates, which has been 
associated with increased risk of chronic renal and rheu-
matic heart disease.11,12
Lesson 3: Skin disfi gurement and weight loss associated with 
recurrent scabies and skin sore infections may have led to child 
contacts being misdiagnosed as victims of parental neglect. 
Recurrent infections can lead to weight loss as a result of 
altered metabolism, nutrient loss and decreased appetite. 
Malnutrition in turn lowers immunity and susceptibility 
to infections.13-15 Thus, in contacts of patients with crusted 
scabies, weight loss and skin disfi gurement associated with 
severe recurrent scabies and skin sores are likely to signify 
ongoing disease transmission from infected patients, rather 
than parental neglect.
Lesson 4: EASCP case management appears to reduce the bur-
den of illness in patients with crusted scabies. Due to the dif-
ferential screening methods used in the intervention (active) 
versus control (passive) periods, the actual reduction in 
recurrences during EASCP preventive care (and duration 
of time patients remained disease-free, compared with 
time spent with active crusting) is likely to be signifi cantly 
greater than the 44% decrease we observed.
Lesson 5: EASCP case management reduces simple scabies 
presentations in sentinel contacts. The decrease we detected 
in presentations of contacts is likely to signify less time 
spent unwell from recurrent scabies and sores and thus less 
suffering, disfi gurement and stigmatisation. EASCP case 
management thus provides a way to reduce the long-term 
disruption to quality of life for these households.10 At the 
community level, our fi ndings suggest the improved con-
trol of an important driver of scabies endemicity.3-5,11 The 
2  Review of cases of crusted scabies and paired contacts before and during 
East Arnhem Scabies Control Program (EASCP) household preventive case 
management
Control (pre-
intervention) 
period
Intervention 
period Change P
Cases (n = 7)
Months audited 99 99 —
Hospital admissions for 
recurrences
9 4 − 56% 0.09
Days in hospital 173 35 − 80% 0.09
EASCP or health centre-
diagnosed recurrences
27 16 − 41% 0.04
Total recurrences (rate per 
year)
36 (4.4) 20 (2.4) − 44% 0.025
Contacts (n = 7)
Months audited 99 99 —
Hospital admissions for 
severe infected scabies
3 0 − 100% 0.16
Days in hospital 13 0 − 100% 0.16
Health centre presentations 
for scabies ± skin sores 25 7 − 72% 0.017
Total scabies-related 
presentations (rate per year)
28 (3.4) 7 (0.8) − 75% 0.017
Paired case–contact 
presentations
64 27 − 58% 0.016
3  Recommendations for implementing the preventive 
care regimen of the East Arnhem Scabies Control 
Program (EASCP)
Wider adoption of the preventive regimen for patients with crusted 
scabies living in scabies-endemic areas will require:
   Ongoing program monitoring and operational research to 
refi ne preventive case management protocols and document 
the transferability of programs
   Active surveillance for recurrences and a chronic disease case 
management approach to crusted scabies care — a long-term 
therapeutic approach is more likely to lead to better outcomes 
than an acute-outbreak approach and to overcome the fear, 
stigma and avoidance of health services evident in most 
patients’ clinical histories
   Support from regional disease control and chronic disease 
programs for health centres to adopt this new model of care in 
communities
   A regional register to facilitate continuity of care when patients 
move between communities — for this, a diagnostic criterion 
for “recurrent” crusted scabies must be developed, and 
we recommend adopting Grades 2–3 of the Royal Darwin 
Hospital grading scale as a criterion for inclusion in ongoing 
preventive care9
   Investigation of the household to exclude contact with crusted 
scabies in situations where recurrent scabies, skin sores and 
weight loss are seen in a child; in households where crusted 
scabies is present, a diagnosis of parental neglect due to 
recurrent scabies and weight loss in children should be made 
with extreme caution
  Urgent research and development to bring easier-to-use and 
more eff ective crusted scabies (and simple scabies) therapies, 
including immunotherapies, to the market  
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reduced infectivity of cases can be explained by two novel 
features of the EASCP preventive care regimen: ongoing 
skin checks, allowing early detection of recurrences; and 
regular use of keratolytic and scabicide agents, both of 
which inhibit mite hyperinfestation.
Recommendations
Based on the EASCP’s preliminary fi ndings, and in light of 
the disruption caused by the condition to affected house-
holds, we recommend that patients with crusted scabies 
living in scabies-endemic areas be offered this preventive 
care regimen. The crusted scabies guidelines in the forth-
coming 6th edition of the CARPA Standard treatment man-
ual have been revised to feature this model of care, and 
our recommendations to facilitate its wider adoption are 
shown in Box 3.
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